PubRank

G E Martorana

Author PubWeight™ 28.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life 2001 1.03
2 New developments in anthracycline-induced cardiotoxicity. Curr Med Chem 2009 1.01
3 Lycopene and cardiovascular diseases: an update. Curr Med Chem 2011 0.98
4 Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 1997 0.97
5 Metal-catalyzed oxidation of human serum albumin: conformational and functional changes. Implications in protein aging. J Biol Chem 1991 0.95
6 Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone). Chem Res Toxicol 1998 0.95
7 Is homocysteine a pro-oxidant? Free Radic Res 2001 0.88
8 Placental alkaline phosphatase determination by inhibition with ethylendiaminetetracetic acid. Clin Chim Acta 1985 0.86
9 Characterization of alkaline phosphatase inactivation by ascorbic acid. Biochim Biophys Acta 1984 0.86
10 Nutritional counselling and oral nutritional supplements in head and neck cancer patients undergoing chemoradiotherapy. J Hum Nutr Diet 2012 0.84
11 Self-similarity properties of alpha-crystallin supramolecular aggregates. Biophys J 1995 0.83
12 Bezafibrate induces a mitochondrial derangement in human cell lines: a PPAR-independent mechanism for a peroxisome proliferator. Chem Res Toxicol 2003 0.83
13 Prooxidant action of desferrioxamine: enhancement of alkaline phosphatase inactivation by interaction with ascorbate system. Arch Biochem Biophys 1990 0.82
14 Conformational stability of bovine alpha-crystallin. Evidence for a destabilizing effect of ascorbate. Biochem J 1992 0.82
15 Alterations of energy metabolism and glutathione levels of HL-60 cells induced by methacrylates present in composite resins. J Dent 2006 0.81
16 Relation between conversion degree and cytotoxicity of a flowable bulk-fill and three conventional flowable resin-composites. Eur Rev Med Pharmacol Sci 2015 0.79
17 Vitamin C-bovine serum albumin binding behaviour. Ital J Biochem 1987 0.78
18 A two-dimensional electrophoresis preliminary approach to human hepatocarcinoma differentiation induced by PPAR-agonists. J Cell Mol Med 2005 0.78
19 The kinetics of concurrent instantaneous and time dependent inhibition of alkaline phosphatase by urea and related compounds. Ital J Biochem 1986 0.78
20 Interaction between alkaline phosphatase and ascorbic acid by fluorescence and absorption studies. Ital J Biochem 1984 0.78
21 Early conformational changes and activity modulation induced by guanidinium chloride on intestinal alkaline phosphatase. Biochem J 1987 0.78
22 Ascorbic acid stability in aqueous solutions. Acta Vitaminol Enzymol 1985 0.78
23 NA+/K+ ATPase impairment and experimental glycation: the role of glucose autoxidation. Free Radic Res 1996 0.78
24 Ascorbic acid and alkaline phosphatase activity. Enzyme 1983 0.78
25 Modifications induced by ascorbic acid on alkaline phosphatase fluorescence. Ital J Biochem 1985 0.78
26 Biochemical properties of alkaline phosphatase from endometrial cancer cells. Enzyme 1985 0.78
27 The relationship between the optical properties and the kinetic behaviour of ascorbate-inhibited alkaline phosphatase. Biochem J 1986 0.78
28 Antioxidant effect of coenzyme Q on hydrogen peroxide-activated myoglobin. Clin Investig 1993 0.77
29 Studies on the selective chemical inhibition by urea of alkaline phosphatase isoenzymes in the reaction course. Enzyme 1984 0.77
30 Enzyme inactivation by metal-catalyzed oxidation of coenzyme Q1. Biochim Biophys Acta 1992 0.77
31 The interaction of short chain coenzyme Q analogs with different redox states of myoglobin. J Biol Chem 1994 0.76
32 Alkaline phosphatase inactivation by mixed function oxidation systems. Arch Biochem Biophys 1987 0.76
33 Mixed function oxidation and enzymes: kinetic and structural properties of an oxidatively modified alkaline phosphatase. Arch Biochem Biophys 1988 0.76
34 Methionine 35 oxidation reduces toxic and pro-apoptotic effects of the amyloid beta-protein fragment (31-35) on isolated brain mitochondria. Neuroscience 2004 0.76
35 Morpho-functional modifications of human neutrophils induced by aqueous cigarette smoke extract: comparison with chemiluminescence activity. Luminescence 2010 0.76
36 Real time control procedures for monitoring SMAC analytical performance. Comput Biol Med 1983 0.75
37 Subcellular distribution of some specific enzymatic activities in human leucocytes. Enzyme 1980 0.75
38 [Thin-layer chromatography separation of L-ascorbic acid from its oxidation products (author's transl)]. Acta Vitaminol Enzymol 1981 0.75
39 Free radical production by activated haem proteins: protective effect of coenzyme Q. Mol Aspects Med 1994 0.75
40 [Colorimetric determination of plasma vitamin C: comparison between 2,4-dinitrophenylhydrazine and phosphotungstic acid methods (author's transl)]. Acta Vitaminol Enzymol 1981 0.75
41 Sample and data random management in a medical laboratory equipped with automatic analysers. J Automat Chem 1982 0.75
42 In vitro effect of ascorbic acid on bovine kidney alkaline phosphatase activity. Acta Vitaminol Enzymol 1983 0.75
43 Modulation of alkaline phosphatase in different organs by ascorbic acid and related compounds. Acta Vitaminol Enzymol 1983 0.75
44 Evaluation of plasma protein antisera affinity by means of turbidimetric assays. Ric Clin Lab 1981 0.75
45 Modification of arginine residues in calf intestinal alkaline phosphatase. Ital J Biochem 1986 0.75
46 Electron transport system in human leukocyte mitochondria. Ital J Biochem 1974 0.75
47 A kinetic approach to the evaluation of alkaline phosphatase inactivation by urea. Ital J Biochem 1984 0.75
48 Comparison of kinetic and optical changes during guanidine denaturation of intestinal alkaline phosphatase. Ital J Biochem 1988 0.75
49 Vitamin C in normal human mononuclear and polymorphonuclear leukocytes. Acta Vitaminol Enzymol 1982 0.75
50 (Na+-K+)-ATPase interaction with L-ascorbic acid. Effect on p-nitrohenylphosphatase partial reaction. Ital J Biochem 1989 0.75
51 Time-resolved fractionation of bone and liver alkaline phosphatase activities with a 'peeling-off' method. Enzyme 1989 0.75